Logo image of GSIW

GARDEN STAGE LTD (GSIW) Stock Fundamental Analysis

USA - NASDAQ:GSIW - KYG3730L1077 - Common Stock

0.1635 USD
+0 (+2.25%)
Last: 10/28/2025, 2:21:27 PM
Fundamental Rating

3

Overall GSIW gets a fundamental rating of 3 out of 10. We evaluated GSIW against 235 industry peers in the Capital Markets industry. While GSIW seems to be doing ok healthwise, there are quite some concerns on its profitability. GSIW is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

GSIW had negative earnings in the past year.
In the past year GSIW has reported a negative cash flow from operations.
GSIW Yearly Net Income VS EBIT VS OCF VS FCFGSIW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -2M -4M -6M

1.2 Ratios

GSIW has a worse Return On Assets (-47.75%) than 94.89% of its industry peers.
GSIW's Return On Equity of -113.28% is on the low side compared to the rest of the industry. GSIW is outperformed by 88.51% of its industry peers.
Industry RankSector Rank
ROA -47.75%
ROE -113.28%
ROIC N/A
ROA(3y)-18.81%
ROA(5y)N/A
ROE(3y)-41.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GSIW Yearly ROA, ROE, ROICGSIW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

GSIW has a better Gross Margin (71.98%) than 78.72% of its industry peers.
In the last couple of years the Gross Margin of GSIW has grown nicely.
The Profit Margin and Operating Margin are not available for GSIW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.82%
GM growth 5YN/A
GSIW Yearly Profit, Operating, Gross MarginsGSIW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 -100 -200 -300

More info and screens

6

2. Health

2.1 Basic Checks

GSIW has about the same amout of shares outstanding than it did 1 year ago.
GSIW has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GSIW Yearly Shares OutstandingGSIW Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 5M 10M 15M
GSIW Yearly Total Debt VS Total AssetsGSIW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

GSIW has an Altman-Z score of 0.66. This is a bad value and indicates that GSIW is not financially healthy and even has some risk of bankruptcy.
GSIW has a Altman-Z score (0.66) which is in line with its industry peers.
There is no outstanding debt for GSIW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.66
ROIC/WACCN/A
WACCN/A
GSIW Yearly LT Debt VS Equity VS FCFGSIW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 5M -5M

2.3 Liquidity

GSIW has a Current Ratio of 1.51. This is a normal value and indicates that GSIW is financially healthy and should not expect problems in meeting its short term obligations.
GSIW has a better Current ratio (1.51) than 65.96% of its industry peers.
GSIW has a Quick Ratio of 1.51. This is a normal value and indicates that GSIW is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.51, GSIW is doing good in the industry, outperforming 65.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
GSIW Yearly Current Assets VS Current LiabilitesGSIW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for GSIW have decreased strongly by -22.45% in the last year.
The Revenue has grown by 185.79% in the past year. This is a very strong growth!
The Revenue has been growing by 33.26% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-22.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.06%
Revenue 1Y (TTM)185.79%
Revenue growth 3Y33.26%
Revenue growth 5YN/A
Sales Q2Q%288.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSIW Yearly Revenue VS EstimatesGSIW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GSIW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GSIW Price Earnings VS Forward Price EarningsGSIW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GSIW Per share dataGSIW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GSIW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GARDEN STAGE LTD

NASDAQ:GSIW (10/28/2025, 2:21:27 PM)

0.1635

+0 (+2.25%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-31 2025-07-31
Earnings (Next)01-23 2026-01-23
Inst Owners3.32%
Inst Owner Change69.57%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap35.67M
Revenue(TTM)6.17M
Net Income(TTM)-7592300
AnalystsN/A
Price TargetN/A
Short Float %0.65%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.78
P/FCF N/A
P/OCF N/A
P/B 5.32
P/tB 5.37
EV/EBITDA N/A
EPS(TTM)-0.49
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.03
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -47.75%
ROE -113.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.98%
FCFM N/A
ROA(3y)-18.81%
ROA(5y)N/A
ROE(3y)-41.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.82%
GM growth 5YN/A
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 371.09%
Cap/Sales 3.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z 0.66
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)195.33%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.57%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)185.79%
Revenue growth 3Y33.26%
Revenue growth 5YN/A
Sales Q2Q%288.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y80.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.8%
OCF growth 3YN/A
OCF growth 5YN/A

GARDEN STAGE LTD / GSIW FAQ

What is the ChartMill fundamental rating of GARDEN STAGE LTD (GSIW) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GSIW.


Can you provide the valuation status for GARDEN STAGE LTD?

ChartMill assigns a valuation rating of 0 / 10 to GARDEN STAGE LTD (GSIW). This can be considered as Overvalued.


How profitable is GARDEN STAGE LTD (GSIW) stock?

GARDEN STAGE LTD (GSIW) has a profitability rating of 1 / 10.